Bionano Genomics (BNGO) Cash from Investing Activities (2017 - 2025)
Bionano Genomics (BNGO) has disclosed Cash from Investing Activities for 9 consecutive years, with $4.0 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities rose 33.77% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.7 million through Dec 2025, down 117.26% year-over-year, with the annual reading at -$12.7 million for FY2025, 117.26% down from the prior year.
- Cash from Investing Activities hit $4.0 million in Q4 2025 for Bionano Genomics, up from -$4.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $47.6 million in Q1 2024 to a low of -$185.6 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged -$5.5 million across 5 years, with a median of $3.5 million in 2024.
- Biggest five-year swings in Cash from Investing Activities: plummeted 7475.59% in 2021 and later skyrocketed 133283.33% in 2022.
- Year by year, Cash from Investing Activities stood at -$92.5 million in 2021, then skyrocketed by 112.55% to $11.6 million in 2022, then crashed by 576.94% to -$55.4 million in 2023, then surged by 105.41% to $3.0 million in 2024, then soared by 33.77% to $4.0 million in 2025.
- Business Quant data shows Cash from Investing Activities for BNGO at $4.0 million in Q4 2025, -$4.7 million in Q3 2025, and $2.0 million in Q2 2025.